Taysha Gene Therapies Inc.

TSHA | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.04

+$0.02 (+0.40%)

At close: Sep 21, 2026, 4:00 PM ET

$4.99

-$0.05 (-1.09%)

Pre-market: Sep 22, 2026, 7:47 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-109M	-89.3M	-111.57M	-166.01M	-174.52M	-60.01M
Depreciation & Amortization	1.15M	1.25M	1.37M	1.17M	492K	9K
Stock-Based Compensation	13.3M	13.1M	7.91M	18.04M	18.18M	3.35M
Other Working Capital	-5.22M	-9.55M	-15.72M	26.32M	14.17M	-2.07M
Other Non-Cash Items	6.83M	6.19M	47.28M	39.89M	10.14M	26.03M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-5.37M	-12.47M	-18.01M	18.52M	28.67M	-111K
Operating Cash Flow	-93.09M	-81.23M	-73.02M	-88.39M	-117.04M	-30.73M
Capital Expenditures	-738K	-374K	-7.37M	-24.87M	-21.55M	-9.08M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	134K	11K	-3.48M	-61K	-6.25M	-9M
Investing Cash Flow	-604K	-363K	-7.35M	-24.93M	-21.55M	-9.08M
Debt Repayment	9.24M	n/a	-3.45M	n/a	39.96M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-337K	-96K	-947K	-1.15M	-514K	n/a
Financial Cash Flow	274.59M	76.68M	136.39M	52.1M	39.08M	291.06M
Net Cash Flow	180.9M	-4.9M	56.02M	-61.22M	-99.51M	251.25M
Free Cash Flow	-93.83M	-81.6M	-80.39M	-113.26M	-138.6M	-39.81M
Adj. Free Cash Flow	-107.13M	-94.7M	-88.29M	-131.3M	-156.78M	-43.17M
Maintenance CapEx	n/a	-374K	n/a	n/a	-492K	-9K
Growth CapEx	-738K	n/a	-7.37M	-24.87M	-21.06M	-9.07M
Owner Earnings	-93.09M	-81.6M	-73.02M	-88.39M	-117.53M	-30.74M